A growing literature has demonstrated a link between early-life socioeconomic conditions and adult health at a singular point in life. No research exists, however, that specifies the life course patterns of socioeconomic status (SES) in relation to the underlying biological processes that determine health. Using an innovative life course research design consisting of four nationally representative longitudinal datasets that collectively cover the human life span from early adolescence to old age (Add Health, MIDUS, NSHAP, and HRS), we address this scientific gap and assess how SES pathways from childhood into adulthood are associated with biophysiological outcomes in different adult life stages. For each dataset, we constructed standardized composite measures of early-life SES and adult SES and harmonized biophysiological measurements of immune and metabolic functioning. We found that the relative importance of early-life SES and adult SES varied across young, mid, and late adulthood, such that early-life SES sets a life course trajectory of socioeconomic wellbeing and operates through adult SES to influence health as adults age. We also documented evidence of the detrimental health effects of downward mobility and persistent socioeconomic disadvantage. These findings are the first to specify the life course patterns of SES that matter for underlying biophysiological functioning in different stages of adulthood. The study thus contributes new knowledge critical for improving population health by identifying the particular points in the life course at which interventions might be most effective in preventing disease and premature mortality.
Introduction
The impacts of social status on physiological, cellular, and molecular processes have been widely documented across species from rodents to nonhuman primates (McClintock et al. 2005; Sapolsky 2005; Tung et al. 2012) . For humans, a large body of work indicates the detrimental consequences of adverse social conditions and social stress for disease susceptibility and survival. Socioeconomic status (SES) is among the most important determinants of the quality of the social environment that strongly condition one's exposures to chronic stress and other risk factors for health (Link and Phelan 1995; Pearlin et al. 1981) . Research across disciplines consistently documents an SES gradient in health, with individuals of lower SES having higher rates of disability, disease, and death than higher SES individuals (Adler and Ostrove 1999; Marmot 2006) . The ubiquity of SES influences on morbidity and mortality brings into sharp focus the need to reduce status-based health disparities.
SES-related disadvantage is not an isolated point in time experience. It reaches across time in individuals' lives. There has been growing interest in examining the early-life origins of SES disparities in health using a life course perspective (Gluckman and Hanson 2004) . A dominant paradigm to explain the early-and later-life connection is the sensitive period model, which posits that exposures during sensitive periods of development (e.g., gestation, birth, childhood, and adolescence) induce enduring structural and functional changes in organisms through biological programming that are difficult to reverse and, in turn, affect later disease risk (Barker 1998; Ben-Shlomo and Kuh 2002; Guo and Harris 2000) . Such a model suggests that early-life conditions have stronger effects on individual outcomes than conditions experienced at subsequent time points. Empirical evidence would support this model if low early-life SES increases the risk of disease in later life, independent of adult SES and other risk factors.
Although the sensitive period model has gained wide recognition and stimulated much research, the causal relationship it implies (i.e., early life exerts direct and permanent impacts on later-life adult health) has never been properly tested or firmly established. Critical gaps remain in our knowledge about mechanisms underlying the early-and laterlife links that are critical for understanding the pathogenesis of diseases of aging. First, it is not clear that the sensitive period model accounts for any observed associations between early SES exposures and later health because most studies have been heavily biased towards examining only early-life periods without consideration of social conditions during the intervening adult years between early-and late-life periods. Second, most studies rely on single indicators of SES (typically occupation) that fail to capture the complex and multidimensional nature of socioeconomic well-being and its potentially varying health impacts across the life course. Third, studies of associations between life course SES and later life morbidity and mortality risks lack examination of underlying biological mechanisms. While evidence has emerged on links between social disadvantage and markers of physiological stress response such as immune compromise (McDade, Lindau, and Wroblewski 2011; Yang, McClintock, et al. 2013 ) and metabolic dysregulation (Sweet et al. 2013; Yang, Li, and Ji 2013) , few extant studies move beyond static snapshots of biomarkers in relation to SES at a point in time and cannot inform the dynamics of their interplay as individuals age. The temporal properties as well as specificity of biological processes involved in the multidimensional SES-health link are important for identifying points of intervention but are largely unknown.
This study addresses these fundamental deficits in past research and provides new data on how early-life SES is related to later-life health. We move beyond the notion of early-life sensitive periods and towards a more comprehensive and integrative framework that considers alternative models and biosocial mechanisms that operate across the human life span.
Besides the sensitive period model, three additional conceptual models have been proposed to explain the early SES and later health link. The accumulation of risks model holds that deleterious prior exposures associated with low SES accumulate to compound the adverse effects over time (Ferraro and Shippee 2009; O'Rand 2009; Willson, Shuey, and Elder 2007) . Statistical evidence for this model is based on the additive effects of earlyand later-life SES factors (Hallqvist et al. 2004 ). The pathway model posits that childhood circumstances affect adult health risk indirectly, such that early experiences set individuals on divergent socioeconomic trajectories that differentially expose them to stressors that impinge on biological functioning and health (Hayward and Gorman 2004; Marmot et al. 2001; Pudrovska and Anikputa 2014) . Statistically, this model predicts that the effects of early-life adversity on later-life disease risk is mediated or transmitted through SES at each subsequent life stage. Lastly, the social mobility model posits that movement across levels of SES may affect disease risk (Hallqvist et al. 2004; Luo and Waite 2005) . This model predicts that the health effects of early-life exposures can be modified by later-life SES such that upward mobility may mitigate negative impacts of early-life adversity, while downward mobility from prosperity to hardship can be a perniciously stressful experience.
These models are often positioned as conceptually distinct, but research documents that the life course processes underlying these models are likely to be complementary rather than mutually exclusive (Hallqvist et al. 2004) . Extant studies show mixed support for different conceptual models and highlight the complexity of interrelated life-course processes (Luo and Waite 2005; Lynch et al. 1994; Lynch, Kaplan, and Shema 1997; Osler et al. 2003; Power, Manor, and Matthews 1999) . Because prior studies often use a crosssectional design in which early-life SES (typically reported retrospectively) is related to adult health at a point in time, the timing and pattern of SES across the life course in relation to underlying biological mechanisms that determine health cannot be examined. As a result, previous research cannot adjudicate among different models or explicate their interrelations, and our current understanding of the early-life impact on adult health remains largely speculative. It is unknown whether early or contemporaneous SES is more important or whether there are windows of particular vulnerability throughout life. Studies have generally failed to consider simultaneously the length of exposures to social conditions, timing of the manifestation of their health impact, and change in social exposures in relation to disease risk measured in multiple life stages as aging progresses. There has been no research we are aware of that offers a robust test of the early-and laterlife link by accounting for all these problems.
This study breaks new ground by examining the SES-health linkages as they unfold across the life span from young adulthood, to midlife, to old age. Combining four nationally representative longitudinal data sets, we assess the extent to which the associations between early and adult SES and biomarkers of inflammation and metabolic syndrome are consistent with the sensitive period, accumulation of risks, pathway, and/ or social mobility models at various stages in the life course. We make several unique contributions to research on social disparities in health. First, the use of an innovative longitudinal research design consisting of multiple large, diverse, population-based samples (Yang et al. 2016 ) enables us to empirically examine early-life SES health impacts over a far more extensive period of life than any single dataset can allow. The comprehensive longitudinal analyses help to better adjudicate among several life course models. Second, this study utilizes multidimensional measures of SES that are harmonized across data sources to provide a more complete view of socioeconomic impacts on health. These measures include parent education, family income, and welfare receipt in early life, and individual education, earnings, and wealth in adulthood. Use of multiple SES indicators allows for a more comprehensive assessment of SES within each life stage and facilitates the comparison of SES-health links across the life span. Third, we use objectively measured biomarkers of immune and metabolic functions that are fundamental in physiological regulation underlying the aging processes leading to morbidity and mortality (Finch 2010) . This study thus provides a mechanistic view of how early life conditions "get under the skin" to influence disease susceptibility over time. Finally, our study design provides new knowledge about whether and how biological pathways linking SES and disease phenotypes may be specific to each life course stage.
Data and Methods
Data for this study come from four nationally representative U.S. National Insitutes of Health studies that collectively span multiple stages of the life course. Data for young adulthood come from 12,237 participants in the National Longitudinal Study of Adolescent to Adult Health (Add Health) aged 12-18 at Wave I (1994 Wave I ( -1995 and followed up at ages 24-32 in Wave IV (2008) (2009) . Data for mid adulthood come from 908 respondents aged 25-74 in the National Survey of Midlife Development in the United States (MIDUS) surveyed at Wave I (1995 Wave I ( -1996 and followed up at Wave II (2004 . Data for late adulthood come from 10,165 participants aged 50 and older in the Health and Retirement Study (HRS) at baseline in 1998 and followed every two years through 2006, as well as 1,026 respondents aged 57-85 in the National Social Life, Health, and Aging Project (NSHAP) at Wave I (2005 Wave I ( -2006 and followed up at Wave II (2010) (2011) . More information about the studies used in this analysis can be found in the Appendix.
Outcome measures represent two key biological pathways underlying the physiological stress process (Finch 2010) . For Add Health, HRS, and NSHAP, immune function was measured using C-reactive protein (CRP), an acute phase protein whose elevation in circulating level indicates systemic inflammation. Additional measures of immune function were available in MIDUS, including fibrinogen, interleukin 6 (IL-6), E-selectin, and intracellular adhesion molecule 1 (ICAM-1), and were used to create a composite score of inflammation burden (Yang, Schorpp, and Harris 2014) . The cut points for CRP reflect clinical reference ranges for health risk, while the top quartile was used as a cut point for the other markers. Metabolic function was assessed by a composite measure that includes seven biomarkers used in the clinical definition of metabolic syndrome: diastolic blood pressure, systolic blood pressure, glycosylated hemoglobin (HbA 1c ), waist circumference, high-density lipoprotein (HDL cholesterol), total cholesterol, and triglycerides. For each measure, the cut points for high risk were defined by clinical practice or defined empirically as the top or bottom decile (see Table 1 for cut points used for each data source). We constructed the index of metabolic syndrome as the sum of the positive indicators. Details of biomarker data collection and assays are provided in the Appendix.
For each data set, measures of both early-life and adult SES were used to examine life course patterns of SES. Early-life SES measures include parental education, household income, welfare receipt, and subjective financial well-being. Parental education was coded as 1 = less than high school, 2 = high school graduate, 3 = some college, and 4 = college graduate or more. For Add Health, MIDUS, and HRS, parent education was measured as the maximum of mother and father education in two-parent households. For NSHAP, mother and father education were incorporated as separate SES indicators. Parent- reported household income was included as an indicator of early-life SES for Add Health and was coded as a continuous measure. While household income in early life was not available for the other data sources, MIDUS included a continuous parent socioeconomic index (SEI) that was based on parent education and occupation, which we used as a proxy for household income. In addition, HRS includes an item that asked respondents if their father was unemployed for a period of several months or more when the respondent was under the age of 16, which was reverse coded to reflect father employment. Welfare receipt was used as an SES indicator for Add Health and MIDUS and was reverse coded to indicate higher SES. Finally, both HRS and NSHAP included a measure of perceived financial well-being, in which respondents were asked whether their family was "pretty well off," "about average," or "poor" when the respondent was before the age of 16. Items were recoded so higher values reflect higher SES. Adult SES measures include respondent education, household income, welfare receipt, and household assets. Respondent education was included in all four data sources and was coded similarly to parent education, with 1 = less than high school, 2 = high school Note. graduate, 3 = some college, and 4 = college graduate or more. Household income was also included for all four data sources and was coded as a continuous measure. For Add Health and MIDUS, welfare receipt was used as an indicator of adult SES and was recoded to reflect higher SES. Finally, NSHAP and HRS included a continuous measure of total household assets, which is an especially important indicator of SES in late adulthood.
Previous research suggests that multivariate scales of SES are more reliable than single measures (Goosby and Walsemann 2012; Walsemann, Bell, and Goosby 2011 ) and reduce problems related to missing data on the SES variables. We constructed composite measures of early-life SES and adult SES that are composed of several indicators of SES available within each data source, resulting in eight composite SES scores (one early-life SES measure and one adult SES measure for all four data sources). For each composite SES score, three individual SES items were first standardized by calculating the z scores for each item. The mean of the three z scores was then calculated to produce a continuous composite SES score. Positive values for the SES scores indicate higher levels of SES. To maximize sample size, composite measures of early-life and adult SES were calculated for all respondents for whom there were data on at least two of the variables used in each scale.
In addition to continuous measures of SES, we also included categorical measures of SES, which indicate social status trajectories using the lowest quartile of each SES composite measure to indicate socioeconomic disadvantage (1 = disadvantaged, 0 = not disadvantaged). Based on the dichotomous SES measure, we constructed measures of change from early to current status that include four categories: persistent disadvantage (disadvantaged-disadvantaged), upward mobility (disadvantaged-not disadvantaged), downwardly mobile (not disadvantaged-disadvantaged), and never disadvantaged (not disadvantaged-not disadvantaged). We included a measure of childhood health in all models to control for health selection early in life. For all four data sources, childhood health was measured using a single item of self-rated health, with response categories of poor, fair, good, very good, and excellent. Information on Add Health childhood health was collected during Wave I of the study, when respondents were adolescents. Childhood health for MIDUS, NSHAP, and HRS was retrospective. Childhood health was operationalized as continuous, with higher values indicating better health. Descriptive statistics on the outcome, SES measures, childhood health, and covariates used in analyses for each of the four data sets are shown in Table 1 .
For each outcome, we conducted two sets of analyses. First, we examined the associations between early-life SES, adult SES, and biomarkers assessed at follow-up using ordinal logit models for both inflammation and metabolic syndrome. We estimated models in a stepwise fashion: (1) Model I adjusts for early-life SES, (2) Model II adjusts for adult SES, and (3) Model III simultaneously adjusts for both early-life and adult SES. We controlled for childhood health in all models to account for potential selection of individuals of varying health status early in life into SES classes in adulthood. Second, to assess the utility of the social mobility model, we modeled the biomarker outcomes as a function of changes across SES categories or movement into and out of SES disadvantage. All models adjust for survey design effects and nonresponse using sampling weights and control for age, sex, race, and marital status. Analyses were conducted in Stata 13.
Results
We found strong associations of SES measures with both indices of physiological functioning across all life stages; however, the relative importance of early-life and adult SES varied across young, mid, and late adulthood, providing evidence consistent with different life course models. As seen in Model I in Table 2 , higher early-life SES is associated with a 15% lower odds of elevated CRP (OR = 0.84, CI = [0.78, 0.91]) and a 20% lower odds of metabolic syndrome (OR = 0.80, CI = [0.74, 0.87]) in the Add Health study. These associations are highly significant and were replicated in the MIDUS, NSHAP, and HRS samples with similar magnitude. In Model II, adult SES showed inverse and significant associations with both physiological outcomes across all life stages, with the effect sizes for inflammation increasing from young to old age.
The simultaneous adjustment for both early-life and adult SES in Model III yields different results across life stage samples. In young and mid adulthood (Add Health and MIDUS), both early-life and adult SES had significant negative associations with CRP/ inflammation burden and metabolic syndrome, suggesting an accumulation of risks model whereby health risks or benefits associated with SES accumulate over the lifetime to additively affect physiological functioning. In late adulthood (NSHAP and HRS), current SES completely mediated the associations between early-life SES and both biomarker outcomes, supporting a pathway model whereby the influence of childhood SES on adult physiology operates through adult SES. Supplementary analyses utilizing structural equation models (SEM) were consistent with the results of the regression analyses presented here and offered additional evidence that adult SES fully mediated the association between early-life SES and the biomarkers in the NSHAP and HRS samples (results available upon request). Results from the SEM models showed that, in both older adult samples, early-life SES indirectly affected the biomarker outcomes through its impact on adult SES. We note that the results using the NSHAP study and the HRS are highly consistent, which shows the robustness of the strong and dominant effects of adult SES in late life. Childhood general health status, while significant in predicting biomarkers in young adulthood, is not consistently associated with biomarkers in other later periods of life. The adjustment of childhood health did not affect the SES-biomarker associations assessed at any point in life. It is thus unlikely that health selection explains any of the above findings.
Analysis of SES change over time provides tentative evidence for the social mobility model across life stages. Figure 1 summarizes the results regarding the associations between different mobility categories and biomarker outcomes. Downward mobility was associated with lower risk of metabolic syndrome in young and middle adulthood than was persistent disadvantage. In young adulthood, for example, we find a 25% lower risk of metabolic syndrome for downwardly mobile individuals, compared to individuals in persistent disadvantage. Upward mobility was also associated with lower risk of inflammation or metabolic syndrome than persistent disadvantage, except in late adulthood. For example, in midlife, upward mobility was associated with a 39% lower risk of metabolic syndrome. The suggestion of adverse health effects associated with upward mobility documented in late adulthood has emerged in other recent research (Miller et al. 2015) . We note, however, the never disadvantaged had lower health risks than all mobility Note. All models adjusted for age, sex, race, marital status, and self-rated health in childhood. ***p < 0.001; **p < 0.01; *p < 0.05.
categories compared. Taken together, we find that SES disadvantage at any point in life put individuals at higher physiological risks for health.
Discussion
Our study contributes new knowledge on the complex temporal dynamics through which SES impacts physiological indicators of health across the life span. Our results demonstrate how SES operates through several life course and biological mechanisms to affect health, and how these mechanisms evolve across young, mid, and late adulthood. In particular, we find that the direct effect of early-life SES on physical health wanes as individuals age, though its indirect effect remains important through its influence on the SES trajectory into adulthood. In early and middle adulthood, we find evidence of an accumulation model, as there are additive and independent associations of both early-life SES and young adult SES with health risks. In old age, early-life SES operates through adult SES in its association with health risks later in the life course, which supports the pathway model. Early-life SES remains salient for health in young to mid adulthood, over and above current adult SES, perhaps because the resources and support that early-life SES provides continue to play an independent role in adult lifestyles and access to health care. Once adults reach old age, the SES they have established as older adults has been fairly stable over many years and early-life SES is important only through its linkage to this longer-term SES. We also find that social mobility matters across the life course. Interestingly, mobility effects do not exist independently from one's location on the SES hierarchy. Regardless of the direction of the movement over time from childhood to adulthood, being in the lowest SES quartile at any point is detrimental to physical health.
SES Mobility and Metabolic Syndrome
Our extensive longitudinal life course study design has offered clear advantages in its ability to adjudicate among different life course models, in contrast to previous research. By examining whether and how early-life SES continues to matter in the presence of adult SES across multiple stages of the adult life course, we are less likely to overlook patterns of associations in the data than previous studies, which evaluated these associations in only one particular period of the life course. Findings that have emerged from this study indicate temporal specificity of exposures to social adversity that can better inform disease intervention and control strategies aimed at minimizing socioeconomic disparities in health. We have thus provided an initial framework for future analysis to incorporate additional datasets and explore the behavioral and psychosocial mechanisms that might explain some of the observed linkages between life course SES and health.
Despite these advances, we acknowledge our study has a number of limitations. First, we lack multiple repeated measures of biomarkers and SES across the early life course, beyond childhood and adolescence, to allow for a closer tracking of SES trajectories across time in relation to subsequent changes in physical indicators. In additional NSHAP analysis where we used two waves of biomarker measures to estimate longitudinal residual change models, we did not find early-life SES to be significantly associated with change in biomarkers over a five-year period in late life. While this is consistent with and strengthens the current finding, it is not known whether the association under question varies by interval length of biomarker measurements within and across life course stages. Second, we cannot exclude the possibility that mortality selection may be occurring with older or frailer adults. The results are thus likely conservative regarding the extent to which early-life and adult SES influence physiological functioning in the older adult population in that those most deprived of SES-related resources earlier in life for whom the SES-biomarker associations tend to be strongest were less likely to have survived to be observed in old age. Third, while the results presented here offer preliminary evidence of the social mobility model, more research incorporating multiple repeated measures of SES is needed. For each of the samples included in the analysis, we have measures of SES at two time points, which limits our ability to fully understand how changes in SES across the life course affect health trajectories, especially among the older aged cohorts for whom childhood occurred 40-60 years ago. Though this study provides initial evidence of an association between social mobility and health risk, more research incorporating longitudinal SES data is needed.
Nonetheless, we provide new scientific data on when and how SES matters for underlying biophysiological functioning across the human life span, which has important implications for interventions to improve population health. It is clear that early-life SES matters for later life health. This finding suggests that policies and interventions aimed at improving the socioeconomic conditions of children in disadvantaged families will reduce SES disparities in health in all stages of the life span-from early adulthood through middle and late adulthood. Interventions designed to enhance the education, training, income, job skills, and job security of parents in low-SES families will directly improve the health of their children as they enter adulthood and set them on an SES trajectory that will continue to benefit their health into old age. Our findings also suggest directions for further research on SES and health. More indepth study of the timing and patterns of SES across the life course and specific biological response to SES-related stress are needed to better understand the lifetime health impacts of SES. The varying life stage relationships between SES and physical health that our study has shown invites follow-up studies to provide deeper mechanistic explanations for the life course development of social disparities in health.
MIDUS II core phone interview and self-administered questionnaire. Fasting wholeblood samples were collected and serum aliquots were assayed for inflammatory markers (hsCRP, fibrinogen, interleukin-6, E-selectin, and intracellular adhesion molecule-1), as well as metabolic indicators (HbA 1c , HDL cholesterol, and triglycerides). Blood pressure and waist circumference were measured by MIDUS staff members during the physical exam. More detailed information about the MIDUS biospecimen collection and protocol can be found in Dienberg Love et al. (2010) .
Analytic samples included respondents with complete data on the variables used in the analyses: inflammation (N = 856) and metabolic syndrome (N = 852). Survey weights are not available for the MIDUS II biomarkers study. To account for sampling of family members, we clustered the sample by family membership and reported robust standard errors.
Health and Retirement Study (HRS)
The Health and Retirement Survey (HRS) is a nationally representative longitudinal survey of the U.S. population aged 50 years and older conducted every two years from 1992 to 2008, using a multistage sampling of households design with an oversample of blacks and Hispanics and overall response rate of about 87% (Heeringa and Connor 1995) . We used information from noninstitutionalized respondents included in the 2006 and 2008 waves who consented to the biomarker collection and completed the blood test. Respondents' blood pressure and waist circumference were measured by trained interviewers, and CRP, HbA 1c , HDL cholesterol, and total cholesterol were collected and assayed using dried blood spots. The physical and blood test consent procedure, laboratory measures, equipment, and protocols are described in Crimmins et al. (2013) .
The final samples for the analyses included respondents with complete data on the variables used in the analyses: CRP (N = 10,165) and metabolic syndrome (N = 9,412). The National Social Life, Health, and Aging Project (NSHAP) is a nationally representative longitudinal study of older adults years in 2005-2006 (Wave 1) and followed up in 2010-2011 (Wave 2). NSHAP Wave 1 used a national area probability sample of community-residing adults ages 57 to 85 at the time of the interview and oversampled AfricanAmerican and Hispanic areas. The original Wave 1 sample included 3,005 respondents, and 2,261 of these Wave 1 respondents were re-interviewed at Wave 2. The overall response rate for Wave 1 was 75.5%, and the response rate for respondents who were re-interviewed at Wave 2 was 87.8%. More information about the survey design can be found in O'Muircheartaigh, Eckman, and Smith (2009) . NSHAP data collection consisted of an in-person questionnaire, biomeasure collection, and a paper leave-behind questionnaire. The in-person questionnaire and biomeasures were administered by an NORC field interviewer in the respondent's home. The independent variables and covariates for the study are drawn from the in-person and leave-behind questionnaires from Waves 1 and 2. Biomarker data are drawn from Wave 2 of the study. To assess levels of hsCRP and HbA 1c , NSHAP collected dried blood spots. Detailed information on the collection of dried blood spots by NSHAP can be found in Williams and McDade (2009) . Respondents completed two or three seated blood pressure (BP) measures on their left arms. We used the mean of each respondent's BP readings. Finally, respondents were weighed, and their height and waist circumference were also measured by the field interviewers.
Each set of analyses used a different sample size, which included respondents with complete data on the variables used in the analysis: CRP (N = 1,026) and metabolic syndrome (N = 988). All analyses used survey weights to adjust for survey design and account for the probability of selection, with post-stratification adjustments for nonresponse based on age and urbanicity.
